0001193125-13-290705.txt : 20130715 0001193125-13-290705.hdr.sgml : 20130715 20130715162557 ACCESSION NUMBER: 0001193125-13-290705 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20130715 DATE AS OF CHANGE: 20130715 GROUP MEMBERS: ANSBERT GADICKE GROUP MEMBERS: JAMES PAUL SCOPA GROUP MEMBERS: JOHN VANDER VORT GROUP MEMBERS: LUKE EVNIN GROUP MEMBERS: MPM ASSET MANAGEMENT INVESTORS BV5 LLC GROUP MEMBERS: MPM BIOVENTURES V GP LLC GROUP MEMBERS: MPM BIOVENTURES V LLC GROUP MEMBERS: TODD FOLEY GROUP MEMBERS: VAUGHN M. KAILIAN SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Verastem, Inc. CENTRAL INDEX KEY: 0001526119 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273269467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-86603 FILM NUMBER: 13968498 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-252-9300 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MPM BIOVENTURES V, L.P. CENTRAL INDEX KEY: 0001482716 IRS NUMBER: 270793842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: MPM ASSET MANAGEMENT STREET 2: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 425-9200 MAIL ADDRESS: STREET 1: MPM ASSET MANAGEMENT STREET 2: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 SC 13D/A 1 d568132dsc13da.htm SC 13D/A SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13D

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)*

 

 

 

Verastem, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

92337C104

(CUSIP Number)

 

Luke B. Evnin

MPM Asset Management

The John Hancock Tower

200 Clarendon Street, 54th Floor

Boston, MA 02116

Telephone: (617) 425-9200

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

June 19, 2013

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

MPM BioVentures V, L.P.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

WC

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

994,702

     8.   

Shared Voting Power

 

0

     9.   

Sole Dispositive Power

 

994,702

   10.   

Shared Dispositive Power

 

0

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

994,702

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.7%(2)

14.

  

Type of Reporting Person (See Instructions)

 

PN

 

(1) This schedule is filed by MPM BioVentures V, L.P. (“BV V”), MPM Asset Management Investors BV5 LLC (“AM LLC”), MPM BioVentures V GP LLC (“BV V GP”), MPM BioVentures V LLC (“BV V LLC”) (collectively, the “MPM Entities”) and Ansbert Gadicke, Luke Evnin, Todd Foley, James Paul Scopa, Vaughn Kailian and John Vander Vort (collectively, the “Listed Persons” and together with the MPM Entities, the “Filing Persons”). The Listed Persons are members of BV V LLC and AM LLC. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 2

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

MPM Asset Management Investors BV5 LLC

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

WC

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

38,631

     8.   

Shared Voting Power

 

0

     9.   

Sole Dispositive Power

 

38,631

   10.   

Shared Dispositive Power

 

0

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

38,631

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

0.2%(2)

14.

  

Type of Reporting Person (See Instructions)

 

OO

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 3

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

MPM BioVentures V GP LLC

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

WC

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

994,702(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

994,702(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

994,702(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.7%(3)

14.

  

Type of Reporting Person (See Instructions)

 

OO

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Represents shares of Common Stock held by BV V. BV V GP and BV V LLC are the direct and indirect general partners of BV V.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 4

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

MPM BioVentures V LLC

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

WC

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

OO

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 5

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

Ansbert Gadicke

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

OO

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

IN

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC. The Reporting Person is a member of BV V LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 6

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

Luke Evnin

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

OO

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

IN

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC. The Reporting Person is a member of BV V LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 7

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

Todd Foley

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

OO

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

IN

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC. The Reporting Person is a member of BV V LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 8

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

James Paul Scopa

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

OO

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

IN

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC. The Reporting Person is a member of BV V LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 9

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

Vaughn M. Kailian

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

OO

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

IN

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC. The Reporting Person is a member of BV V LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 10

CUSIP No. 92337C104  

 

  1.   

Name of Reporting Persons. I.R.S. Identification No(s). of above person(s) (entities only)

 

John Vander Vort

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ¨        

(b)  x (1)

 

  3.  

SEC USE ONLY

 

  4.  

Source of Funds (See Instructions)

 

OO

  5.  

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

  6.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      7.    

Sole Voting Power

 

0

     8.   

Shared Voting Power

 

1,033,333(2)

     9.   

Sole Dispositive Power

 

0

   10.   

Shared Dispositive Power

 

1,033,333(2)

11.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,033,333(2)

12.

  

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

  

Percent of Class Represented by Amount in Row (11)

 

4.9%(3)

14.

  

Type of Reporting Person (See Instructions)

 

IN

 

(1) This Schedule is filed by the MPM Entities and the Listed Persons. The MPM Entities and the Listed Persons expressly disclaim status as a “group” for purposes of this Schedule 13D.
(2) Includes 994,702 shares of Common Stock held by BV V and 38,631 shares of Common Stock held by AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC. The Reporting Person is a member of BV V LLC.
(3) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.

 

Page 11

This Amendment No. 1 to Schedule 13D (this “Schedule 13D”) amends and supplements the Schedule 13D previously filed by the undersigned with the Securities and Exchange Commission on February 10, 2012 (as amended, the “Original Schedule 13D”). This Schedule 13D/A is being filed to report the open market sales of shares of common stock of Verastem, Inc. (the “Issuer”) by the MPM Entities.

All capitalized terms not otherwise defined herein shall have the meaning ascribed to the terms in the Original Schedule 13D. The Original Schedule 13D is hereby further amended and supplemented as follows and, except as expressly amended below, the Original Schedule 13D remains in full force and effect.

 

Item 4. Purpose of Transaction

Item 4 of the Original Schedule 13D is hereby amended and supplemented by adding the following paragraph at the end of Item 4:

The MPM Entities sold an aggregate of 1,000,000 shares of Common Stock in open market transactions from January 7, 2013 through July 8, 2013 for aggregate proceeds of $13,122,040.

 

Item 5. Interest in Securities of the Issuer

“Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety as follows:

(a) – (b) The following information with respect to the ownership of the common stock of the Issuer by the Reporting Persons is provided as of July 8, 2013:

 

Reporting Person

    Shares
Held
Directly		      Sole
Voting
Power		      Shared
Voting
Power		      Sole
Dispositive
Power		      Shared
Dispositive
Power		      Beneficial
Ownership		      Percentage
of Class
(1)		  

BV V

      994,702         994,702         0         994,702         0         994,702         4.7 % 

AM LLC

      38,631         38,631         0         38,631         0         38,631         0.2 % 

BV V GP(2)

      0         0         994,702         0         994,702         994,702         4.7 % 

BV V LLC(3)

      0         0         1,033,333         0         1,033,333         1,033,333         4.9 % 

Ansbert Gadicke(4)

      0         0         1,033,333         0         1,033,333         1,033,333         4.9 % 

Luke Evnin(4)

      0         0         1,033,333         0         1,033,333         1,033,333         4.9 % 

Todd Foley(4)

      0         0         1,033,333         0         1,033,333         1,033,333         4.9 % 

James Paul Scopa(4)

      0            1,033,333         0         1,033,333         1,033,333         4.9 % 

Vaughn Kailian(4)

      0            1,033,333         0         1,033,333         1,033,333         4.9 % 

John Vander Vort(4)

      0         0         1,033,333         0         1,033,333         1,033,333         4.9 % 

 

(1) This percentage is calculated based upon 21,289,319, shares of the Issuer’s common stock outstanding on April 30, 2013, as disclosed in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 9, 2013.
(2) Includes securities held by BV V. BV V GP and BV V LLC are the direct and indirect general partners of BV V.
(3) Includes securities held by BV V and AM LLC. BV V GP and BV V LLC are the direct and indirect general partners of BV V and BV V LLC is the manager of AM LLC.
(4) Includes securities held by BV V and AM LLC. The Reporting Person is a member of BV V LLC.

 

Page 12

(c) The Reporting Persons sold the following shares of Common Stock in the open market in the sixty days preceding the date of this filing:

 

Date of Sale

    Sold by
MPM
BV V		      Sold By
AM
LLC		      Price
Per
Share		  

6/13/2013

      33,577         1,305       $ 11.12   

6/14/2013

      12,514         486       $ 11.13   

6/17/2013

      21,177         823       $ 11.12   

6/18/2013

      20,729         805       $ 11.70   

6/19/2013

      40,429         1,571       $ 12.24   

6/20/2013

      16,364         636       $ 12.33   

6/21/2013

      13,476         524       $ 12.58   

6/24/2013

      24,807         964       $ 12.44   

6/25/2013

      11,661         453       $ 12.58   

6/26/2013

      67,484         2,621       $ 13.28   

6/27/2013

      96,260         3,740       $ 13.59   

6/28/2013

      74,482         2,894       $ 13.87   

7/1/2013

      21,177         823       $ 14.15   

7/2/2013

      19,252         748       $ 14.24   

7/3/2013

      8,663         337       $ 14.08   

7/5/2013

      30,802         1,198       $ 14.51   

7/8/2013

      14,783         574       $ 14.68   

7/8/2013

      343,648         13,352       $ 14.00   

The information provided and incorporated by reference in Item 3 and Item 6 is hereby incorporated by reference in this Item 5.

(d) Not applicable.

(e) On July 8, 2013, the Reporting Persons ceased to be beneficial owners of more than 5% of the issued and outstanding Common Stock of the Company. The reporting obligations of the Reporting Persons with respect to the Common Stock pursuant to Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder are therefore terminated.

 

Item 7. Material to Be Filed as Exhibits

Item 7 of the Original Schedule 13D is hereby supplemented by adding the following in appropriate order:

C. Agreement regarding filing of joint Schedule 13D/A.

 

Page 13

Signatures

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: July 15, 2013
MPM BIOVENTURES V GP LLC
By:  

MPM BioVentures V LLC,

its Managing Member

By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
MPM BIOVENTURES V LLC
By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
MPM BIOVENTURES V, L.P.
By:   MPM BioVentures V GP LLC, its General Partner
By:   MPM BioVentures V LLC, its Managing Member
By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
By:   MPM BioVentures V LLC
  Its: Manager
By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
By:  

/s/ Ansbert Gadicke

Name:   Ansbert Gadicke
By:  

/s/ Luke B. Evnin

Name:   Luke Evnin
By:  

/s/ Todd Foley

Name:   Todd Foley

 

Page 14

By:  

/s/ James Paul Scopa

Name:   James Paul Scopa
By:  

/s/ Vaughn M. Kailian

Name:   Vaughn M. Kailian
By:  

/s/ John Vander Vort

Name:   John Vander Vort

 

Page 15

Exhibit Index

 

C.    Agreement regarding filing of joint Schedule 13D.

 

Page 16

EX-99.C 2 d568132dex99c.htm EX-C EX-C

Exhibit C

Joint Filing Statement

I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the beneficial ownership by the undersigned of the equity securities of Verastem, Inc. is filed on behalf of each of the undersigned.

Date: July 15, 2013

 

MPM BIOVENTURES V GP LLC

By: MPM BioVentures V LLC,

  its Managing Member

By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
MPM BIOVENTURES V LLC
By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
MPM BIOVENTURES V, L.P.
By:   MPM BioVentures V GP LLC, its General Partner
By:   MPM BioVentures V LLC, its Managing Member
By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
By:   MPM BioVentures V LLC
  Its: Manager
By:  

/s/ Luke B. Evnin

Name:   Luke B. Evnin
Title:   Member
By:  

/s/ Ansbert Gadicke

Name:   Ansbert Gadicke
By:  

/s/ Luke B. Evnin

Name:   Luke Evnin

 

Page 17

By:   /s/ Todd Foley
Name:   Todd Foley
By:   /s/ James Paul Scopa
Name:   James Paul Scopa
By:   /s/ Vaughn M. Kailian
Name:   Vaughn M. Kailian
By:   /s/ John Vander Vort
Name:   John Vander Vort

 

Page 18